Expanding horizons for the targeted management of EGFR-positive NSCLC
On demand Janssen satellite symposium from the virtual ESMO Congress 2021
Agenda
Video recording by the congress organisers of the Janssen Symposium from the ESMO Congress 2021 that took place on 18 September.
Learning objective:
After watching this broadcast, participants should be able to:
- Reflect on novel management paradigms for patients with EGFR+ NSCLC, who are resistant to EGFR targeted therapies
- Evaluate new and emerging diagnostic and therapeutic options for EGFR exon 20 insertion mutations
Scientific Committee:
- Keith Kerr (UK)
- David Planchard (France)
Faculty:
- Johan Vansteenkiste (Netherlands)
- Alexander Spira (USA)
Accreditation for this educational activity has been requested for at CPDUK, a globally recognised provider of CPD:
